Key facts
- This page summarizes Olsen Per Wold's Form 4 filing for GILEAD SCIENCES INC (GILD).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 May 2021, 19:02.
Olsen Per Wold - 06 May 2021 Form 4 Insider Report for GILEAD SCIENCES INC (GILD)
- Reporting relationship
- Director
- Issuer ticker
- GILD
- Reported as of
- 06 May 2021
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 07 May 2021, 19:02:38 UTC
- Next SEC filing
- 13 Jan 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Amy Kim by Power of Attorney for Per Wold-Olsen
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Olsen Per Wold filed Form 4 for GILEAD SCIENCES INC (GILD) on 07 May 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GILD
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,936
- Change %
- +1.9%
- Price
- Shares after
- 102,060
- Date
- 06 May 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GILD
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -1,936
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 06 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,936
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
Footnote F2
100% of the restricted stock units vested on May 6, 2021.